Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Molina-Cerrillo

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Critical Reviews in Oncology/Hematology|October 18, 2022
Epigenetics in advanced renal cell carcinoma: Potential new targetsJavier Molina-Cerrillo, Matteo Santoni, Álvaro Ruiz, et al.
Cancers|December 23, 2022
Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?Javier Pozas, Sara Álvarez Rodríguez, Víctor Albarrán Fernández, et al.
International Journal of Molecular Sciences|July 17, 2020
Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: From Biology to TherapyMaría San Román Gil, Javier Pozas, Javier Molina-Cerrillo, et al.
Case Reports in Otolaryngology|September 10, 2016
Primary Neuroendocrine Tumor of the Parotid Gland: A Case Report and a Comprehensive Review of a Rare EntityOlga Martínez-Sáez, Javier Molina-Cerrillo, Carmen Moreno García Del Real, et al.
Cancers|January 21, 2023
Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic ConsequencesMatteo Santoni, Javier Molina-Cerrillo, Giorgio Santoni, et al.
Communications Medicine|May 27, 2026
Microplastics as both a driver of genitourinary cancers and a deliverer of treatmentsKannan Sridharan, Brigida Anna Maiorano, Farah Rehan, et al.
Future Oncology (London, England)|February 26, 2025
STELLAR-304: a phase III study of zanzalintinib (XL092) plus nivolumab in advanced non-clear cell renal cell carcinomaSumanta K Pal, Thomas Powles, Ravindran Kanesvaran, et al.
Cancers|June 18, 2020
BRAF Mutated Colorectal Cancer: New Treatment ApproachesJavier Molina-Cerrillo, María San Román, Javier Pozas, et al.
Critical Reviews in Oncology/Hematology|June 19, 2022
Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survivalMatteo Santoni, Fernando Sabino M Monteiro, Francesco Massari, et al.
Cancers|December 10, 2021
Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell CarcinomaPablo Álvarez Ballesteros, Jesús Chamorro, María San Román-Gil, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Critical Reviews in Oncology/Hematology|October 18, 2022
Epigenetics in advanced renal cell carcinoma: Potential new targetsJavier Molina-Cerrillo, Matteo Santoni, Álvaro Ruiz, et al.
Cancers|December 23, 2022
Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?Javier Pozas, Sara Álvarez Rodríguez, Víctor Albarrán Fernández, et al.
International Journal of Molecular Sciences|July 17, 2020
Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: From Biology to TherapyMaría San Román Gil, Javier Pozas, Javier Molina-Cerrillo, et al.
Case Reports in Otolaryngology|September 10, 2016
Primary Neuroendocrine Tumor of the Parotid Gland: A Case Report and a Comprehensive Review of a Rare EntityOlga Martínez-Sáez, Javier Molina-Cerrillo, Carmen Moreno García Del Real, et al.
Cancers|January 21, 2023
Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic ConsequencesMatteo Santoni, Javier Molina-Cerrillo, Giorgio Santoni, et al.
Communications Medicine|May 27, 2026
Microplastics as both a driver of genitourinary cancers and a deliverer of treatmentsKannan Sridharan, Brigida Anna Maiorano, Farah Rehan, et al.
Future Oncology (London, England)|February 26, 2025
STELLAR-304: a phase III study of zanzalintinib (XL092) plus nivolumab in advanced non-clear cell renal cell carcinomaSumanta K Pal, Thomas Powles, Ravindran Kanesvaran, et al.
Cancers|June 18, 2020
BRAF Mutated Colorectal Cancer: New Treatment ApproachesJavier Molina-Cerrillo, María San Román, Javier Pozas, et al.
Critical Reviews in Oncology/Hematology|June 19, 2022
Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survivalMatteo Santoni, Fernando Sabino M Monteiro, Francesco Massari, et al.
Cancers|December 10, 2021
Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell CarcinomaPablo Álvarez Ballesteros, Jesús Chamorro, María San Román-Gil, et al.
Pageof 10